Evidence map›Paper›PMID 25994661›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2015

Moderator's view: Biomarkers in glomerular diseases--translated into patient care or lost in translation?

Pierre Ronco

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Glomerular Diseases: Registries and Clinical Trials.Clinical journal of the American Society of Nephrology : CJASN · 2016
    Article
  4. Nephrology research--the past, present and future.Nature reviews. Nephrology · 2015
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Pierre RoncoSorbonne Universités, UPMC Univ Paris 06, UMR_S 1155, Paris F-75005, France INSERM, UMR_S 1155, Batiment Recherche, Hôpital Tenon, 4 rue de la Chine, Paris F-75020, France Department of Nephrology and Dialysis, AP-HP, Hôpital Tenon, Paris F-75020, France.
Assistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diagnostic ErrorsMolecular Targeted TherapyPrecision MedicineBiomarkersDiabetic NephropathiesGlomerulosclerosis, Focal SegmentalHumansKidney DiseasesKidney GlomerulusLupus NephritisBiomarkers

Identifiers

PMID25994661
OpenAlexW1886095054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.